APA (7th ed.) Citation

Groheux, D., Biard, L., Lehmann-Che, J., Teixeira, L., Bouhidel, F. A., Poirot, B., . . . de Cremoux, P. (2018). Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer. European Journal of Nuclear Medicine & Molecular Imaging, 45(8), 1279. https://doi.org/10.1007/s00259-018-3998-z

Chicago Style (17th ed.) Citation

Groheux, David, et al. "Tumor Metabolism Assessed by FDG-PET/CT and Tumor Proliferation Assessed by Genomic Grade Index to Predict Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging 45, no. 8 (2018): 1279. https://doi.org/10.1007/s00259-018-3998-z.

MLA (9th ed.) Citation

Groheux, David, et al. "Tumor Metabolism Assessed by FDG-PET/CT and Tumor Proliferation Assessed by Genomic Grade Index to Predict Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 45, no. 8, 2018, p. 1279, https://doi.org/10.1007/s00259-018-3998-z.